• Edit
DateInvestorsAmountRound
-

N/A

-
N/A

SGD100k

Angel

$1.0m

Angel
N/A

N/A

Early VC

$500k

Seed

$5.0m

Series A
N/A

$2.0m

Series A

$35.0m

Series B

$100m

Valuation: $700m

Series C
*

$300m

Valuation: $1.3b

Series D
*

$20.0m

Valuation: $1.5b

Series D
Total Funding€421m

Recent News about Biofourmis

Edit
More about Biofourmisinfo icon
Edit

Biofourmis is a digital health company that leverages advanced technology to provide hospital-level care in the comfort of patients' homes. The company serves healthcare providers, pharmaceutical companies, and patients by offering a predictive health platform that uses biosensors and deep learning algorithms to monitor and analyze patient data. Operating in the healthcare technology market, Biofourmis' business model revolves around selling its platform and services to hospitals and healthcare systems, as well as partnering with pharmaceutical companies to enhance drug efficacy and patient outcomes. The company generates revenue through subscription fees, service contracts, and partnerships. By focusing on predictive analytics and personalized care, Biofourmis aims to prevent costly medical events and improve patient outcomes.

Keywords: predictive analytics, digital health, biosensors, deep learning, hospital-at-home, personalized care, healthcare technology, remote monitoring, patient outcomes, pharmaceutical partnerships.

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.

Investments by Biofourmis

Edit
Biovotion
ACQUISITION by Biofourmis Nov 2019
Gaido Health
ACQUISITION by Biofourmis Apr 2020